Shan Liu

No ORCID on file · 7 papers in corpus · active 2010-2023

Study types

  • article 2
  • other 1
  • retraction 1
  • review 1

Condition tags

  • endometriosis 3
other 2023
BMJ open ·doi:10.1136/bmjopen-2023-076390

BACKGROUND: Uterine contractions may interfere with embryo implantation in assisted reproductive technology. To reduce these contractions and improve success rates, the oxytocin antagonist atosiban has been suggested for administration duri…

retraction 2023
Reproductive toxicology (Elmsford, N.Y.) ·doi:10.1016/j.reprotox.2023.108364
2023
BMC women's health ·doi:10.1186/s12905-023-02195-5

BackgroundWith the development of assisted reproduction technology (ART), many indicators have been proposed to evaluate ovarian response, and then predict pregnancy outcomes. In general, the predictive values remain limited.ObjectiveTo fur…

article 2022
·doi:10.1007/s43032-022-00875-5

This study explored the impact of low luteinizing hormone (LH) levels during ovarian stimulation on endometrial function. Based on previous studies by us and others, we divided the patients into low ( 10 IU/L) LH groups. The study utilized …

review 2022
Reproductive toxicology (Elmsford, N.Y.) ·doi:10.1016/j.reprotox.2022.07.007

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief. The journal was contacted by the cor…

2021
BMJ open ·doi:10.1136/bmjopen-2020-047974

IntroductionMany patients demonstrate an insufficient endogenous luteinising hormone (LH) concentration during ovarian stimulation. With traditional fixed or flexible gonadotropin-releasing hormone (GnRH) antagonist protocols, antagonist ad…

article 2010
·doi:10.1188/10.onf.e133-e140

PURPOSE/OBJECTIVES: To explore patterns of symptoms over time and the relationships between selected demographic and clinical characteristics. DESIGN: Secondary analysis of longitudinal data. SETTING: A hospital and comprehensive cancer cen…